Non hdl cholesterol meaning
Pro Research Analysisby 
Searched over 200M research papers
Understanding Non-HDL Cholesterol: Definition, Importance, and Implications
Definition of Non-HDL Cholesterol
Non-HDL cholesterol is defined as the total cholesterol in the blood minus the high-density lipoprotein (HDL) cholesterol. It includes all the cholesterol contained in lipoproteins that are considered atherogenic, such as very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), intermediate-density lipoprotein (IDL), and lipoprotein (a) (Lp(a)), as well as chylomicrons and their remnants 1.
Importance of Non-HDL Cholesterol in Cardiovascular Risk Assessment
Predictor of Atherosclerotic Cardiovascular Diseases (ASCVD)
Non-HDL cholesterol is increasingly recognized as a significant marker for estimating the risk of developing atherosclerotic cardiovascular diseases (ASCVD). Elevated levels of non-HDL cholesterol in adolescence have been strongly linked to the development of ASCVD in adulthood, highlighting its importance in early risk assessment 1.
Comparison with Other Lipid Measures
While non-HDL cholesterol is a useful predictor of cardiovascular risk, some studies suggest that the total-to-HDL cholesterol ratio might be more informative, especially in specific populations such as those with type 2 diabetes 3. However, non-HDL cholesterol remains a strong predictor of cardiovascular disease (CVD) in diabetic patients, often outperforming LDL cholesterol and triglycerides alone 6.
Non-HDL Cholesterol and Triglycerides
Impact of Triglyceride Levels
The relationship between non-HDL cholesterol and triglycerides is complex. In conditions like hypertriglyceridemia, non-HDL cholesterol levels can be influenced by the presence of larger, less atherogenic triglyceride-rich lipoproteins. As triglyceride levels increase, non-HDL cholesterol may include more cholesterol from these larger lipoproteins, which are less atherogenic than LDL and remnant lipoproteins 2. This indicates that triglyceride levels can affect the accuracy of non-HDL cholesterol as a marker for atherogenic lipoproteins.
Goal Attainment in Diabetic Patients
In diabetic patients with cardiovascular disease, achieving non-HDL cholesterol goals is often suboptimal, particularly at higher triglyceride levels. This is due to the continuous increase in triglyceride-rich lipoproteins, which complicates the attainment of non-HDL cholesterol targets 7.
Global Trends and Implications
Shifts in Non-HDL Cholesterol Levels
Global trends indicate a shift in non-HDL cholesterol levels, with increases observed in low- and middle-income countries, particularly in East and Southeast Asia, and decreases in high-income Western countries. This shift underscores the need for population-based policies and personal interventions to manage cholesterol levels worldwide 5.
Long-term Cardiovascular Risk
Extended elevations of non-HDL cholesterol across a lifespan are associated with increased cardiovascular risk. Early monitoring of non-HDL cholesterol levels, especially before the age of 40, can help identify individuals at high risk for long-term cardiovascular events, facilitating early preventive measures 9.
Conclusion
Non-HDL cholesterol is a crucial marker for cardiovascular risk assessment, encompassing all atherogenic lipoproteins. Its levels are influenced by various factors, including triglyceride concentrations, and it serves as a significant predictor of cardiovascular diseases, particularly in diabetic patients. Global trends in non-HDL cholesterol levels highlight the need for targeted interventions to manage cardiovascular risk effectively. Early monitoring and goal attainment are essential for reducing long-term cardiovascular risk associated with elevated non-HDL cholesterol.
Sources and full results
Most relevant research papers on this topic
Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood.
Elevated non-HDL cholesterol levels in early adolescence strongly predict the development of atherosclerotic cardiovascular diseases in adulthood.
Literature ReviewCalculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
As serum triglyceride levels increase, calculated non-HDL cholesterol gradually includes more cholesterol from larger triglyceride-rich lipoproteins, which are less atherogenic than LDL and remnant lipoproteins.
Observational Study
Rigorous JournalNon-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes.
Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes patients.
Observational StudyRigorous JournalNational trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
HDL cholesterol has risen and the total-to-HDL cholesterol ratio has declined in many Western countries, Japan, and South Korea, with only a weak correlation with total cholesterol or non-HDL cholesterol changes.
Meta-AnalysisRepositioning of the global epicentre of non-optimal cholesterol
From 1980 to 2018, total and non-HDL cholesterol levels increased in low- and middle-income countries, particularly in east and southeast Asia, and decreased in high-income western countries.
Meta-AnalysisRigorous Journal
Highly CitedNon-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study.
Non-HDL cholesterol is a strong predictor of cardiovascular disease risk in patients with diabetes, particularly for coronary events.
Observational StudyRigorous JournalHighly CitedNon-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Non-HDL cholesterol goal attainment is suboptimal in people with diabetes and co-existing CVD, with higher triglyceride levels being more significant.
Observational StudyMeta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
Lowering non-HDL-C by 1% in most lipid-modifying drugs has a 1:1 relationship with reducing coronary heart disease risk.
Meta-AnalysisHighly CitedTrajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.
Early lipid monitoring before 40 years of age can identify most individuals with high lifetime elevated lipid levels and a high long-term risk for cardiovascular disease.
Observational StudyHighly CitedNon-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals.
Non-HDL cholesterol is more strongly associated with subclinical atherosclerosis than all other conventional lipid values, suggesting it as an important treatment target in primary prevention.
Observational StudyHighly Cited